Dore, Gregory J.

Restrictions for Medicaid Reimbursement of Sofosbuvir for the Treatment of Hepatitis C Virus Infection in the United States

Barua, S., Greenwald, R., Grebely, J., Dore, G. J., Swan, T., & Taylor, L. E. (2015) · Annals of Internal Medicine

Hepatitis C virus researchPharmaceutical Economics and Policy

Cited by 401

A multinational Delphi consensus to end the COVID-19 public health threat

Lazarus, J. V., Romero, D., Kopka, C. J., Karim, S. A., Abu-Raddad, L. J., Almeida, G., Baptista-Leite, R., Barocas, J. A., Barreto, M. L., Bar-Yam, Y., et al. (2022) · Nature

COVID-19 epidemiological studiesLegal, Health, Environmental and COVID-19 Challenges

Cited by 226

Disseminated Microsporidiosis Due to Septata intestinalis in Nine Patients Infected with the Human Immunodeficiency Virus: Response to Therapy with Albendazole

Dore, G. J., Marriott, D. J., Hing, M. C., Harkness, J. L., & Field, A. S. (1995) · Clinical Infectious Diseases

Parasitic Infections and DiagnosticsViral gastroenteritis research and epidemiology

Cited by 94

Hepatitis C virus prevalence and outcomes among injecting drug users on opioid replacement therapy

HALLINAN, R., BYRNE, A., AMIN, J., & DORE, G. J. (2005) · Journal of Gastroenterology and Hepatology

Hepatitis C virus researchHIV, Drug Use, Sexual Risk

Cited by 56

Declining Incidence of Hepatitis C Virus Infection among People Who Inject Drugs in a Canadian Setting, 1996-2012

Grebely, J., Lima, V. D., Marshall, B. D. L., Milloy, M.-J., DeBeck, K., Montaner, J., Simo, A., Krajden, M., Dore, G. J., Kerr, T., et al. (2014) · PLoS ONE

Hepatitis C virus researchHIV, Drug Use, Sexual Risk

Cited by 48

Mortality in a large community-based cohort of inner-city residents in Vancouver, Canada

Deans, G. D., Raffa, J. D., Lai, C., Fischer, B., Krajden, M., Amin, J., Walter, S. R., Dore, G. J., Grebely, J., & Tyndall, M. W. (2013) · CMAJ Open

HIV, Drug Use, Sexual RiskHomelessness and Social Issues

Cited by 15